Overview
Legal name
BIP CONSULTING UK LIMITED
Region
London
Registered address
51 MOORGATE
LONDON
ENGLAND
EC2R 6LL
Insolvency history
No
Company
Active
LTD
Company profile
Chaucer Group Limited
The Chaucer Group Chaucer
The Chaucer Group Chaucer
CRN
02136429
Founded
1987
Age
39
Corporate ownership
Updated 06 Jun 2026 16:52
1
Company
Active
LTD
Chaucer Group Limited
CRN 02136429
2
Direct controller
Active
LTD
Chaucer Management Services Limited
CRN 08816533
3
Intermediate controller
Active
LTD
Chaucer Management Holdings Limited
CRN 08816534
4
Intermediate controller
Active
LTD
Bip Consulting UK Limited
CRN 12667981
5
Ultimate controller
Active
OVERSEA-COMPANY
Bip Spa
CRN FC031174
Company events
Reference milestones and recent Companies House filing stream events.
9 events
23 Dec
2026
Confirmation statement due
Confirmation DueNext confirmation statement due date
30 Sep
2026
Accounts due
Accounts DueNext accounts due date
09 Dec
2025
Confirmation statement filed
ConfirmationLast confirmation statement made up date
21 Feb
2025
Certificate Change Of Name Company
Change-of-nameCERTNM | Transaction MzQ1NTk5NDU0MWFkaXF6a2N4
Published 21 Feb 2025 02:52
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
13 Nov
2024
Legacy
OtherAGREEMENT2 | Transaction MzQ0MzE1NzU5OWFkaXF6a2N4 | Paper/PDF filed
Published 13 Nov 2024 07:25
15 Aug
2024
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzMjM4NDM3MGFkaXF6a2N4
Published 15 Aug 2024 18:08
07 Aug
2024
Legacy
OtherGUARANTEE2 | Transaction MzQzMTUxMDcyMmFkaXF6a2N4 | Paper/PDF filed
Published 07 Aug 2024 13:20
01 Jun
1987
Incorporated
InceptionCompany registered at Companies House
Public funding
1 award
First funded
2018
Funded years
2018
Age at first award
30 years
Projects
2018
Collaborative R&D
A coordinated strategy to scale-up advanced therapies for patients in Manchester
1 Mar 2018 to 30 Apr 2022
Awarded
£51,337
Total cost £85,561
"Advance Therapies are a new generation of treatments which use patients' cells as 'drug' to treat a variety of diseases. Although encouraging results have been reported, this technology is complex, expensive and currently only available to small numbers of patients. We have formed the Innovate Manchester Advanced Therapy Centre Hub (iMATCH); this is a gr...
Product types
Collaborative R&D